Skip to content

AXIOM INVESTORS LLC /DE: CMG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of AXIOM INVESTORS LLC /DE on CMG, newest first. How the timeline and the estimate are built.

AXIOM INVESTORS LLC /DE held 0 CMG shares at 2025-09-30 per its 13F-HR filed 2025-11-14.

the latest 13F is the newest step

  1. period ended2025-09-30
    13F 0 shares
    Change vs previous 13F -649,076 shares

    13F-HR 0001109147-25-000008 filed by AXIOM INVESTORS LLC /DE
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-06-30
    13F 649,076 shares
    Change vs previous 13F -2,268,701 shares

    0.3% of the 13F portfolio, value $36,445,617.

    13F-HR 0001109147-25-000005 filed by AXIOM INVESTORS LLC /DE
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-03-31
    13F/A 2,917,777 shares
    Change vs previous 13F -163,678 shares

    1.41% of the 13F portfolio, value $146,501,583.

    13F-HR/A 0001109147-25-000004 filed by AXIOM INVESTORS LLC /DE
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-12-31
    13F 3,081,455 shares
    Change vs previous 13F +868,240 shares

    1.37% of the 13F portfolio, value $185,811,736.

    13F-HR 0001109147-25-000001 filed by AXIOM INVESTORS LLC /DE
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-09-30
    13F 2,213,215 shares
    Change vs previous 13F not available

    1.12% of the 13F portfolio, value $127,525,448.

    13F-HR 0001109147-24-000007 filed by AXIOM INVESTORS LLC /DE
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).